GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Capricor Therapeutics Inc. (CAPR) [hlAlert]

Rating:
Buy NLTX
down 95.35 %

NILE THERAPEUTICS (NLTX) rated Buy with price target $7.50 by Maxim Group

Posted on: Friday,  Nov 14, 2008  9:25 AM ET by Maxim Group

Maxim Group rated Buy Capricor Therapeutics Inc. (NASDAQ: CAPR) on 11/14/2008, when the stock price was $93.00. Since
then, Capricor Therapeutics Inc. has lost 95.35% as of 08/27/2015's recent price of $4.32.
If you would have followed this Maxim Group's recommendation on CAPR, you would have lost 95.35% of your investment in 2477 days.

Nile Therapeutics, Inc. (Nile) is a development-stage biopharmaceutical company in the business of commercially developing products for the treatment of cardiovascular diseases. The Company?s product CD-NP, a chimeric natriuretic peptide is in Phase II clinical studies for the treatment of heart failure. The Company is developing CD-NP for an initial indication of acute decompensated heart failure (ADHF). The Company is also developing CU-NP, a pre-clinical rationally designed natriuretic peptide that consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type natriuretic peptide (CNP), and the N- and C-termini of Urodilatin (URO).

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/14/2008 9:25 AM Buy
None
93.00 375.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy